BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Genetown

  UV Flu Technologies Inc. Executes Online Sales Agreement for ViraTech UV-400

  January 5, 2011

   · 

  3 min read
• Deals

  Teva Pharmaceutical Industries Limited Completes Acquisition of Theramex SpA

  January 5, 2011

   · 

  1 min read
• Business

  Water Street Healthcare Partners Acquires OraPharma, Inc.; Recruits Janet Vergis as CEO

  January 5, 2011

   · 

  3 min read
• Business

  AVI BioPharma, Inc. and Leading Researchers at Karolinska Institute Form Collaboration to Identify RNA-Based Therapeutic Candidates for Treatment of Extensively Drug-Resistant Tuberculosis (XDR-TB)

  January 5, 2011

   · 

  5 min read
• Business

  University of California, Berkeley (CAL) Licenses Novel Antifibrinolytic Agents from University of California

  January 5, 2011

   · 

  5 min read
• Business

  Pacific Biomarkers, Inc. Establishes Scientific Advisory Board

  January 5, 2011

   · 

  7 min read
• Biotech Bay

  Portola Pharmaceuticals, Inc. Announces Presentation at J.P. Morgan’s 29th Annual Healthcare Conference

  January 5, 2011

   · 

  1 min read
• Business

  NuPathe Inc. Appoints William J. Federici to Its Board of Directors

  January 5, 2011

   · 

  2 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Initiates Randomized Phase II Trial of Bavituximab in Pancreatic Cancer

  January 5, 2011

   · 

  6 min read
• Genetown

  Ariad Pharmaceuticals, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference

  January 5, 2011

   · 

  1 min read